Cannabis extract, but not Δ1-tetrahydrocannabinol, inhibits human brain and liver monoamine oxidase
- 1 January 1984
- journal article
- research article
- Published by Elsevier in General Pharmacology: The Vascular System
- Vol. 15 (2) , 171-174
- https://doi.org/10.1016/0306-3623(84)90104-6
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- ACTIVITY OF CANNABIS IN RELATION TO ITS Δ‘‐trans‐TETRAHYDROCANNABINOL CONTENTBritish Journal of Pharmacology, 1981
- Lipid substitution of mitochondrial monoamine oxidase can lead to the abolition of clorgyline selective inhibition without alteration in the A/B ratio assessed by substrate utilisationBiochemical Pharmacology, 1980
- The effect of lipid-depletion on the kinetic properties of rat liver monoamine oxidase-BJournal of Pharmacy and Pharmacology, 1980
- Exposure of mitochondrial outer membranes to neuraminidase selectively destroys monoamine oxidase A activityJournal of Pharmacy and Pharmacology, 1980
- On rat liver mitochondrial monoamine oxidase activity and lipidsArchives of Biochemistry and Biophysics, 1978
- Lysolecithin is a selective reversible inhibitor of mitochondrial monoamine oxidaseBiochemical Pharmacology, 1978
- A model for the selective mode of action of the irreversible monoamine oxidase inhibitors clorgyline and deprenyl, based on studies of their ability to activate a Ca2+-Mg2+ ATPase in defined lipid environmentsJournal of Pharmacy and Pharmacology, 1977
- Osmotic fragility of liposomes as affected by antihemolytic compoundsBiochimica et Biophysica Acta (BBA) - Biomembranes, 1974
- Stabilization of rat erythrocyte membrane by △1-tetrahydrocannabinolLife Sciences, 1971
- Some observations upon a new inhibitor of monoamine oxidase in brain tissueBiochemical Pharmacology, 1968